News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,778 Results
Type
Article (39728)
Company Profile (247)
Press Release (659803)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204189)
Career Advice (2008)
Deals (35420)
Drug Delivery (95)
Drug Development (81049)
Employer Resources (172)
FDA (16189)
Job Trends (14865)
News (345227)
Policy (32545)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49448)
ALS (93)
Alzheimer's disease (1382)
Antibody-drug conjugate (ADC) (132)
Approvals (16186)
Artificial intelligence (261)
Autoimmune disease (22)
Automation (16)
Bankruptcy (360)
Best Places to Work (11637)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (290)
Cancer (2306)
Cardiovascular disease (179)
Career advice (1677)
Career pathing (30)
CAR-T (153)
Cell therapy (432)
Cervical cancer (20)
Clinical research (66065)
Collaboration (853)
Company closure (2)
Compensation (557)
Complete response letters (19)
COVID-19 (2590)
CRISPR (41)
C-suite (249)
Cystic fibrosis (101)
Data (2297)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6380)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (86981)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (112615)
Executive appointments (737)
FDA (17552)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (764)
Gene editing (109)
Generative AI (19)
Gene therapy (308)
GLP-1 (716)
Government (4427)
Grass and pollen (4)
Guidances (150)
Healthcare (18819)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (121)
Indications (29)
Infectious disease (2734)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (312)
IPO (16522)
IRA (40)
Job creations (3633)
Job search strategy (1422)
Kidney cancer (10)
Labor market (43)
Layoffs (475)
Leadership (17)
Legal (7910)
Liver cancer (76)
Lung cancer (324)
Lymphoma (156)
Machine learning (9)
Management (58)
Manufacturing (322)
MASH (73)
Medical device (13383)
Medtech (13388)
Mergers & acquisitions (19466)
Metabolic disorders (702)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1929)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (40)
Obesity (371)
Opinion (204)
Ovarian cancer (80)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (150)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (46)
People (57337)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20579)
Phase II (29101)
Phase III (21668)
Pipeline (1344)
Policy (146)
Postmarket research (2563)
Preclinical (8755)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (382)
Real estate (5907)
Recruiting (65)
Regulatory (22323)
Reports (47)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (131)
Series B (87)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3579)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (30)
Vaccines (697)
Venture capitalists (42)
Weight loss (236)
Women's health (36)
Worklife (16)
Date
Last 7 days (927)
Last 30 days (2928)
Last 365 days (32333)
2025 (11662)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54085)
2019 (46539)
2018 (35026)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37872)
Australia (6190)
California (6366)
Canada (2059)
China (532)
Colorado (271)
Connecticut (278)
Delaware (156)
Europe (81380)
Florida (946)
Georgia (212)
Idaho (57)
Illinois (545)
India (25)
Indiana (318)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (918)
Massachusetts (4727)
Michigan (223)
Minnesota (401)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1782)
New Mexico (28)
New York (1794)
North Carolina (985)
North Dakota (8)
Northern California (2801)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1417)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (25)
South Dakota (1)
Southern California (2398)
Tennessee (105)
Texas (944)
United States (23852)
Utah (188)
Virginia (151)
Washington D.C. (64)
Washington State (561)
West Virginia (3)
Wisconsin (56)
699,778 Results for "medisca inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Medisca Opens New Pharmaceutical Repackaging Facility to Meet Global Demands in Personalized Medicine
Medisca, a global leader in personalized pharmaceutical solutions, held a grand opening event on June 20, 2024, for their new repackaging and distribution facility in Plattsburgh, New York.
June 27, 2024
·
4 min read
Policy
Medisca Takes Steps to Protect its Innovative Technologies
Through decades of strategic research and development investment, the Medisca name has become synonymous with innovative, customer-focused technologies.
September 26, 2023
·
2 min read
Deals
Medisca Acquires all IP assets of Maxima Pharmaceuticals Including the DIFFUSIMAX® Brand
On May 31, 2022, Medisca, a global supplier of pharmaceutical compounding products, acquired DIFFUSIMAX® and DIFFUSIMAX®10 liposomal bases (pluronic lecithin organogel or PLO gel), products used for preparing compounded topical formulations, as well as all intellectual property assets of Maxima Pharmaceuticals.
June 28, 2022
·
2 min read
Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA
Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd.
May 26, 2022
·
3 min read
Press Releases
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
May 8, 2025
·
4 min read
Press Releases
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
May 7, 2025
·
3 min read
Press Releases
Exagen Inc. Prices Public Offering of Common Stock
May 8, 2025
·
3 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025
May 7, 2025
·
5 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Press Releases
Exagen Inc. Announces Proposed Public Offering of Common Stock
May 8, 2025
·
3 min read
1 of 69,978
Next
